HYFT
ImmunoPrecise Antibodies Ltd.
1.40$
-4.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.7% | -36.0% | +16.4% | -0.6% | +122.7% | +30.9% | +5.1% | +58.7% | -5.4% | -0.8% | -2.0% | +2.8% | +16.4% | +27.6% | +2.7% | -9.2% | +26.3% | -5.0% | +8.0% | -5.9% | +2.9% | +2.0% | +8.8% | -10.5% | +10.6% | +8.4% | +1.2% | +8.1% | +1.2% | +3.8% | -61.7% | +8.3% | +129.6% | +13.5% | -54.7% | +30.5% | -0.8% | -0.3% | -4.5% | – | |
| – | -48.4% | -9.8% | -41.4% | +140.8% | +43.8% | -6.3% | +29.6% | +37.2% | +0.8% | -14.3% | +83.6% | -35.3% | -49.8% | +169.3% | +21.6% | -38.4% | +45.1% | -51.5% | +120.3% | -0.8% | +3.1% | +3.8% | -13.7% | +14.9% | +8.8% | -5.2% | +26.9% | +10.5% | -5.4% | +10.8% | -56.3% | -10.5% | +118.0% | -11.7% | -35.2% | -10.5% | +14.0% | -3.6% | +0.4% | – | |
| – | – | -66.3% | +376.3% | -92.2% | +1,042.8% | +85.5% | -13.1% | +82.4% | -10.6% | +11.9% | -63.6% | +141.1% | +80.9% | -10.7% | -12.6% | +24.0% | +15.7% | +27.7% | -22.0% | -9.8% | +2.8% | +0.4% | +28.2% | -25.2% | +12.1% | +20.2% | -16.3% | +5.7% | +8.2% | -2.8% | -67.5% | +35.5% | +140.7% | +35.4% | -65.8% | +74.3% | -8.9% | +2.0% | -7.8% | – | |
| – | – | – | +440.4% | -73.0% | +11.9% | -45.6% | +496.0% | -91.8% | -39.4% | +211.7% | +214.2% | -11.3% | +166.6% | -87.8% | +307.8% | +39.8% | +239.5% | – | – | +81.8% | +172.0% | -32.4% | -56.0% | +582.7% | -19.1% | -90.0% | +88.6% | -11.8% | +19.9% | -7.4% | +60.6% | -32.4% | +5.1% | +3.0% | -3.7% | +16.8% | -2.5% | +30.4% | -16.2% | – | |
| – | -35.5% | +188.1% | +53.7% | -38.1% | +74.9% | +61.7% | -5.2% | +12.2% | -4.1% | -9.7% | +7.7% | +1.6% | +14.2% | -52.1% | +165.2% | -26.6% | +34.4% | +38.0% | +18.1% | -10.5% | -18.7% | +12.2% | +61.6% | -25.6% | -9.5% | +73.9% | -40.2% | -17.0% | +26.3% | -1.4% | -18.6% | -14.9% | +25.9% | +3.1% | -11.1% | -6.7% | +60.2% | +6.7% | +35.0% | – | |
| – | -54.8% | +185.6% | +136.1% | -46.3% | +54.9% | +47.6% | +33.4% | -11.6% | +3.8% | -5.1% | +66.2% | -28.7% | +22.3% | -30.5% | +37.6% | -24.9% | +37.8% | +31.0% | +16.2% | +12.1% | +23.2% | -5.3% | +9.0% | +64.3% | -13.8% | -11.3% | -70.2% | +81.2% | +29.1% | +1.3% | -13.3% | -5.6% | +21.5% | -10.2% | -4.0% | -4.5% | +11.3% | +12.0% | +25.7% | – | |
| – | -31.1% | -588.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +70.8% | -42.5% | +117.1% | -53.1% | +70.8% | -42.5% | +2,611.5% | +226.1% | -0.2% | -34.9% | +29.8% | +4.9% | -13.5% | -28.3% | +31.5% | +13.3% | -11.6% | -30.2% | +16.4% | -25.9% | -3.3% | +15.9% | -17.1% | -50.8% | – | – | -81.6% | +1.2% | -1.8% | -19.0% | -49.7% | +50.9% | +1.8% | -37.5% | – | – | – | – | – | – | |
| – | -32.1% | -3,894.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -32.1% | -71.8% | -2,822.3% | – | – | – | – | -65.9% | +308.3% | -61.8% | -517.7% | – | – | +138.1% | -488.0% | – | -70.2% | +64.8% | +1,047.3% | -81.6% | +1.1% | +9.5% | +32.2% | -246.5% | – | – | – | – | – | – | – | – | – | – | -134.9% | – | -170.8% | – | – | – | |
| – | -32.1% | -4,486.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.4% | -3,562.0% | – | – | – | – | – | – | – | – | – | – | – | – | -74.8% | +471.2% | +3.2% | -112.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.